CSIMarket
 


Organogenesis Holdings Inc   (ORGO)
Other Ticker:  
 
 

ORGO's Net Income Growth by Quarter and Year

Organogenesis Holdings Inc 's Net Income results by quarter and year




ORGO Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 51.70 18.49 -3.75
III Quarter September 0.22 12.58 20.93 -11.39
II Quarter June 8.74 20.69 -5.17 -9.65
I Quarter March 0.09 9.94 -16.31 -15.67
FY   9.05 94.91 17.94 -40.46



ORGO Net Income third quarter 2022 Y/Y Growth Comment
Organogenesis Holdings Inc reported drop in Net Income in the third quarter 2022 by -98.29% to $ 0.22 millions, from the same quarter in 2021.
The fall in the third quarter 2022 Organogenesis Holdings Inc 's Net Income compares unfavorably to the Company's average Net Income rise of 29.33%.

Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 47 other companies have achieved higher Net Income growth. While Organogenesis Holdings Inc ' s Net Income meltdown of -98.29% ranks overall at the positon no. 1917 in the third quarter 2022.




ORGO Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 179.61 % - -
III Quarter September -98.29 % -39.89 % - -
II Quarter June -57.76 % - - -
I Quarter March -99.09 % - - -
FY   - 429.04 % - -

Financial Statements
Organogenesis Holdings Inc 's third quarter 2022 Net Income $ 0.22 millions ORGO's Income Statement
Organogenesis Holdings Inc 's third quarter 2021 Net Income $ 12.58 millions Quarterly ORGO's Income Statement
New: More ORGO's historic Net Income Growth >>


ORGO Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 310.97 % -11.66 % -
III Quarter September -97.54 % -39.2 % - -
II Quarter June 9611.11 % 108.15 % - -
I Quarter March -99.83 % -46.24 % - -
FY (Year on Year)   - 429.04 % - -




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #48
Healthcare Sector #144
Overall #1917

Net Income Y/Y Growth Statistics
High Average Low
146.28 % 29.33 % -16.91 %
(Mar 31 2021)   (Sep 30 2022)
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #48
Healthcare Sector #144
Overall #1917
Net Income Y/Y Growth Statistics
High Average Low
146.28 % 29.33 % -16.91 %
(Mar 31 2021)   (Sep 30 2022)

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Organogenesis Holdings Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
9950.57 % 1038.91 % -100 %
(Jun 30 2022)  


ORGO's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2022 Organogenesis Holdings Inc disclosed fall in Net Income sequentially by -97.54% to $ 0.22 millions, from $ 8.74 millions released in the previous quarter.

If you evaluate present slump at the III. Quarter, you must assume, that frequently III. Quarter 2022 results emerge sluggish in contrast to the second quarter

Within Major Pharmaceutical Preparations industry 42 other companies have achieved higher Net Income quarter on quarter growth. While Organogenesis Holdings Inc 's Net Income growth quarter on quarter, overall rank is 2259.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #43
Healthcare Sector #148
Overall #2259
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #43
Healthcare Sector #148
Overall #2259
Net Income Q/Q Growth Statistics
High Average Low
9950.57 % 1038.91 % -100 %
(Jun 30 2022)  


ORGO's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2022 Organogenesis Holdings Inc realized fall in Net Income from the second quarter by -97.54% to $ 0.22 millions, from $ 8.74 millions achived in the previous quarter.

When you analyse recent downturn in the quarter, you must take into consideration, that commonly III. Quarter 2022 results appear to be weaker then in the second quarter

Within Major Pharmaceutical Preparations industry 42 other companies have achieved higher Net Income quarter on quarter growth. While Organogenesis Holdings Inc 's Net Income growth quarter on quarter, overall rank is 2259.


Organogenesis Holdings Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ 60.74 $ 73.10 $ 85.05 $ 94.90 $ 61.70
Y / Y Net Income Growth (TTM) -1.56 % 4.35 % 92.39 % 428.73 % -
Year on Year Net Income Growth Overall Ranking # 1050 # 1124 # 432 # 132 # 0
Seqeuential Net Income Change (TTM) -16.91 % -14.04 % -10.39 % 53.81 % -11.93 %
Seq. Net Income Growth (TTM) Overall Ranking # 1917 # 2050 # 1741 # 232 # 1698




Cumulative Net Income growth Comment
For the 12 months ended Sep 30 2022 Organogenesis Holdings Inc reported a decrease in Net Income by -1.56% year on year, to $61 millions, compare to the 4.35% growth at Jun 30 2022.

In the Healthcare sector 70 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1050, from total ranking in previous quarter at 1124.

Net Income TTM Q/Q Growth Statistics
High Average Low
146.28 %
29.33 %
-16.91 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 48
Healthcare Sector # 71
Overall # 1050

Net Income TTM Y/Y Growth Statistics
High Average Low
428.73 %
130.98 %
-1.56 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 48
Sector # 144
S&P 500 # 1917
Cumulative Net Income growth Comment
For the 12 months ended Sep 30 2022 Organogenesis Holdings Inc reported a decrease in Net Income by -1.56% year on year, to $61 millions, compare to the 4.35% growth at Jun 30 2022.

In the Healthcare sector 70 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1050, from total ranking in previous quarter at 1124.

Net Income TTM Q/Q Growth Statistics
High Average Low
146.28 %
29.33 %
-16.91 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 48
Healthcare Sector # 71
Overall # 1050

Net Income TTM Y/Y Growth Statistics
High Average Low
428.73 %
130.98 %
-1.56 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 48
Sector # 144
S&P 500 # 1917




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ORGO's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ORGO's Competitors
Net Income Growth for Organogenesis Holdings Inc 's Suppliers
Net Income Growth for ORGO's Customers

You may also want to know
ORGO's Annual Growth Rates ORGO's Profitability Ratios ORGO's Asset Turnover Ratio ORGO's Dividend Growth
ORGO's Roe ORGO's Valuation Ratios ORGO's Financial Strength Ratios ORGO's Dividend Payout Ratio
ORGO's Roa ORGO's Inventory Turnover Ratio ORGO's Growth Rates ORGO's Dividend Comparisons



Companies with similar Net Income decrease for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Pediatrix Medical Group Inc -0.19%$ -0.195 millions
Addus Homecare Corporation-0.29%$ -0.294 millions
Royalty Pharma Plc-0.62%$ -0.623 millions
Zoetis Inc -4.35%$ -4.348 millions
Henry Schein Inc -4.41%$ -4.410 millions
Charles River Laboratories International inc -7.18%$ -7.177 millions
Sotera Health Company-8.58%$ -8.577 millions
U S Physical Therapy Inc-9.22%$ -9.219 millions
Ironwood Pharmaceuticals inc -9.90%$ -9.899 millions
Te Connectivity Ltd -10.83%$ -10.831 millions
Semler Scientific inc -11.45%$ -11.446 millions
National Research Corporation-14.07%$ -14.073 millions
Lemaitre Vascular Inc-16.11%$ -16.113 millions
Intuitive Surgical Inc -16.14%$ -16.142 millions
Molecular Templates Inc -18.92%$ -18.919 millions
Regeneron Pharmaceuticals Inc -19.39%$ -19.391 millions
Universal Health Services Inc -19.40%$ -19.402 millions
Zynex inc -20.21%$ -20.206 millions
Progyny Inc -21.34%$ -21.344 millions
Khosla Ventures Acquisition Co -22.51%$ -22.507 millions
Tenax Therapeutics Inc -23.22%$ -23.222 millions
Maravai Lifesciences Holdings Inc -24.97%$ -24.966 millions
Reynolds Consumer Products Inc -27.27%$ -27.273 millions
Taitron Components Incorporated-28.61%$ -28.614 millions
Merck and Co Inc -28.83%$ -28.834 millions
Organon and Co -29.72%$ -29.721 millions
Gilead Sciences Inc -30.94%$ -30.936 millions
West Pharmaceutical Services Inc -31.32%$ -31.321 millions
Abbott Laboratories-31.67%$ -31.667 millions
Surgery Partners Inc -31.71%$ -31.707 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CIFR's Profile

Stock Price

CIFR's Financials

Business Description

Fundamentals

Charts & Quotes

CIFR's News

Suppliers

CIFR's Competitors

Customers & Markets

Economic Indicators

CIFR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071